Fwd: [LDN_Users] FLU REDEUX

[Guest guest]

This was sent to the LDN USERS group by Dr. Skip.. he's

THE pharmacist expert on LDN. He's based in Florida, if I remember

correctly.

Yvette

---------- Forwarded message ----------

Date: Mon, Jan 18, 2010 at 11:50 AM

Subject: [LDN_Users] FLU REDEUX

To: LDN_Users

*Did the World Health Organization (WHO) Experts Exaggerate the Swine Flu

Scare?*

Questions are being raised about whether the swine flu scare was exaggerated

to benefit PHARMA companies. Evidence has surfaced that several members of

the World Health Organization's (WHO) vaccine board which pushed countries

to buy the H1N1 vaccine have had significant ties with PHARMA companies.

This fact was exposed by Danish news media last month. Attempts were made to

get WHO's response, but several emails sent to the office of the WHO

director-general on January 9 met with no response. Documents revealed that

Prof Juhani Eskola, a Finnish member of the WHO board on vaccines,

" Strategic Advisory Group of Experts " (SAGE), received almost 6.3 million

Euros in 2009 for his vaccine research program from the vaccine

manufacturers, GSK, qualifying GSK as THL's main source of income. A Danish

newspaper pointed out that SAGE advises WHO Chief Margaret Chan and

recommends which vaccines and how much of its member countries should

purchase. The journalists reported on six other members of SAGE with

financial ties to various pharmaceutical companies, including manufacturers

of vaccines (including the H1N1 vaccine) like GlaxoKline (GSK),

Novartis, Solvay, Baxter, MedImmune, and Sanofi-Aventis. Only one of the WHO

members on the vaccine board declared any conflict of interest despite

having extensive financial ties with the pharmaceutical companies in the

form of research grants and consultancies.

http://pharmalive.com/news/index.cfm?articleID=678738 & categoryid=9 & newsletter=1

*Serbia to Stop Import of Swine Flu Vaccines*

Serbia's health officials say they will stop the purchase of swine flu

vaccines from a Swiss pharmaceutical company because of the lack of demand.

Last year Serbia ordered 3 million doses of the vaccine from Novartis AG.

The estimated worth of the order was estimated at (EURO) 24 million ($35

million US). Serbia has received and paid for about 850,000 doses, while

only some 135,000 people -- about 2 percent of the population -- have been

vaccinated.

http://pharmalive.com/news/index.cfm?articleID=678349 & categoryid=9 & newslette<htt\

p://pharmalive.com/news/index.cfm?articleID=678349 & categoryid=9 & newsletter=1>

--

Yvette

Freelance Writer

Managing Editor, Brighthub.com Google Channel

http://www.brighthub.com/internet/google.aspx

Omaha Natural Health Examiner

http://www.examiner.com/x-16397-Omaha-Natural-Health-Examiner

ifreelance.com portfolio

http://www.ifreelance.com/pro/72177